-
Mashup Score: 1Teclistamab in Relapsed or Refractory Multiple Myeloma | NEJM - 2 year(s) ago
Original Article from The New England Journal of Medicine — Teclistamab in Relapsed or Refractory Multiple Myeloma
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
#Teclistamab in #Relapsed or Refractory #MultipleMyeloma 👇 A nice addition to existing therapies! 👉https://t.co/6OTuSXt4uf @CHUnantes🇫🇷| @Szusmani @DoctorAKrishnan #CD3 https://t.co/iEXvVXQvmf